Today marks World Cancer Day 2022. With 10 million deaths per year, cancer is the second leading cause of death in the world. At OREGA Biotech we are committed to discover and develop novel cancer immunotherapies. We thank our collaborators and partners with whom we work hard to achieve this goal !
Professor Martine Bagot and Professor Armand Bensussan are rewarded for their research on the development of a targeted therapy, lacutamab, a monoclonal antibody targeting the tumor antigen KIR3DL2 for the treatment of patients with advanced, refractory and relapsed T cell lymphomas, particularly erythrodermic cutaneous T cell lymphomas. The Galien Prize here rewards two decades of research.